IL-2 and GM-CSF can not only stimulate the proliferation and cytotoxicity of TILs in the presence of tumor cells [27] but also promote the activation and cytotoxicity of monocytes to attack melanoma in vitro [28, 29] and prolong the survival of polymorphonuclear neutrophils [30]. The gene discussed is CSF2; the disease is melanoma.